Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003023998 | SCV003329875 | likely benign | Nemaline myopathy 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004960914 | SCV005451825 | uncertain significance | Inborn genetic diseases | 2024-10-29 | criteria provided, single submitter | clinical testing | The c.3527A>G (p.D1176G) alteration is located in exon 33 (coding exon 31) of the NEB gene. This alteration results from a A to G substitution at nucleotide position 3527, causing the aspartic acid (D) at amino acid position 1176 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |